Amlodipine-associated Angioedema.
Lee Mikyung L ML, Delijani David D, Vittorio Timothy T, Lee David N DN et al.
Astellas Pharma · AGTR1 · Small Molecule
telmisartan + amlodipine is a small molecule developed by Astellas Pharma. It is approved for therapeutic indications via oral (po).
| Brand Names | Micamlo BP, Onduarp, Micamlo AP |
| Company | Astellas Pharma |
| Drug Class | Small Molecule |
| Molecular Target | AGTR1, CACNA1C |
| Route | Oral (PO) |
| Status | Approved |
telmisartan + amlodipine acts on 2 molecular targets:
| AGTR1 | angiotensin II receptor type 1 (HAT1R, AT1) |
| CACNA1C | calcium voltage-gated channel subunit alpha1 C (CACNL1A1, CACNA1C-IT2) |
telmisartan + amlodipine is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Vascular disorders | Hypertension | ✓ Approved |
Lee Mikyung L ML, Delijani David D, Vittorio Timothy T, Lee David N DN et al.
Saki Najmaldin N, Kast Richard Eric RE, Bahreiny Seyed Sobhan SS, Aghaei Mojtaba M
Doxorubicin is a chemotherapeutic agent widely recognized for its efficacy in cancer treatment but also associated with a significant risk of inducing cardiomyopathy, both acutely and over the long term. The underlying mechanisms of myocardial damage involve the generation of reactive oxygen species (ROS), myocardial infiltration by neutrophils, elevated levels of myeloperoxidase (MPO) and tumor necrosis factor-alpha (TNF-α), as well as an increase in cardiac xanthine oxidase (XO) activity. This review presents and evaluates the burgeoning field of interventions aimed at reducing the cardiotoxicity associated with doxorubicin, a potent chemotherapeutic agent. To mitigate doxorubicin-induced cardiotoxicity, we introduce a novel therapeutic approach termed the dapsone, febuxostat, telmisartan (DFT) therapy. This regimen involves the administration of dapsone, febuxostat, and telmisartan-compounds known for their cardioprotective effects. This review synthesizes findings from the literature, detailing how each component of the DFT regimen contributes to cardioprotection through mechanisms such as the attenuating oxidative stress and inflammation, and modulating cardiac enzyme activities. Research on the DFT regimen has yielded encouraging outcomes in attenuating doxorubicin-induced cardiotoxicity. Dapsone, febuxostat, and telmisartan, both individually and in combination, have demonstrated a capacity to protect the heart by inhibiting ROS production, diminishing neutrophil infiltration, reducing levels of MPO and TNF-α, and suppressing XO activity. Furthermore, these agents are implicated in preserving cardiac function, preventing myocardial injury, and averting adverse remodeling. The DFT therapy presents a promising approach to reducing the cardiotoxic effects associated with doxorubicin in cancer patients. The collective evidence suggests that the DFT regimen not only attenuates doxorubicin-induced cardiotoxic effects but also preserves cardiac function, prevents myocardial injury, and averts adverse remodeling, underscoring its potential as an adjunctive therapy. Nonetheless, further preclinical and clinical studies are essential to confirm the cardioprotective efficacy of this regimen and to refine its application in oncology.
Niu Qinghua Q, Sun Ting T, Li Mingxuan M, Du Lianfang L et al.
To evaluate whether targeted ultrasound (TUS) combined with contrast-enhanced ultrasound (CEUS) can safely reclassify MRI-detected BI-RADS 4 nonmass enhancement (NME) lesions to reduce unnecessary biopsies while maintaining high diagnostic sensitivity for breast cancer. In this prospective study (2017-2023), we enrolled 169 MRI-detected BI-RADS 4 NME lesions in 167 women (23-84 years). All patients underwent TUS and CEUS within one week after MRI, followed by surgical pathology. We evaluated whether TUS combined with CEUS could reclassify lesions to avoid biopsy without compromising cancer detection. Among 169 lesions (83 benign, 86 malignant), TUS detected 97.0%. Using predefined CEUS benign criteria, 36/83 benign lesions (43.4%) and 39/169 overall (23.1%) could have safely avoided biopsy. Diagnostic sensitivity remained high (96.5%, 83/86). CEUS significantly improved detection of DCIS, upgrading 87.5% (21/24) of MRI-BI-RADS 4a DCIS/DCIS with microinvasion to BI-RADS ≥4b. False-negative cases were limited to three lesions in challenging anatomical locations (subareolar or occult). Biopsy reduction was highest in asymptomatic patients, lesions ≤ 2 cm, homogeneous enhancement, and MRI BI-RADS 4a. TUS combined with CEUS can substantially reduce unnecessary biopsies for MRI-detected BI-RADS 4 NME while maintaining excellent sensitivity. This approach is particularly effective for MRI BI-RADS 4a lesions and small homogeneous NME and may provide a clinically practical strategy for improving diagnostic efficiency in breast cancer care.
Massera Alice A, Vacaru Stefania V SV, Xing Jiayin J, Waters Theodore E A TEA et al.
Postnatal maternal anxiety shapes caregiver and infant behavior. Yet, the relationship with infant brain function remains unclear. We examine the relation of maternal anxiety with infant resting state functional connectivity (rsFC). To evaluate the clinical significance of the rsFC networks identified, exploratory analyses tested whether the rsFC associated with maternal anxiety moderates risk trajectories from infant behavioral inhibition (BI) to childhood anxiety/depression symptoms. Four-month-old infants (N = 60) underwent resting-state functional magnetic resonance imaging (fMRI), and mothers completed the Beck Anxiety Inventory (BAI). Analyses included 49 infants with high-quality imaging and maternal anxiety data. In the longitudinal subsample (n = 21), BI was observed at 14 months, and anxiety/depression symptoms were assessed at 4-6 years using the Child Behavior Checklist (CBCL). Using whole-brain network enrichment analyses, we identified cortical network pairs that were significantly associated with maternal anxiety. Connectivity estimates from significant network pairs were averaged and tested as moderators of infant BI and childhood anxiety/depression association. Infants exposed to higher maternal anxiety showed an altered limbic-dorsal attention network (DAN) and default mode (DMN)-DAN. In both network pairs, negative and positive node-to-node pairs were identified, indicating that some regional connections exhibited stronger coupling, while others exhibited weaker coupling. Results demonstrated that DMN-DAN rsFC moderated developmental pathways: greater BI was associated with higher early-childhood anxiety/depression among infants with stronger DMN-DAN connectivity. Maternal anxiety is related to infant brain connectivity, and these neural differences moderate BI-related risk for anxiety/depression. DMN-DAN coupling may serve as an early marker of infants at risk for anxiety/depression. Given the small longitudinal sample, the moderation finding should be considered exploratory and requires replication in a larger, independent cohort.
Chantelot Louise L, Amar Yael Y, Duchateau Magalie M, Giai Gianetto Quentin Q et al.
Invasive fungal diseases (IFDs) are increasingly recognized in immunocompromised patients, but diagnosis remains challenging because current pathogen-targeted perform variably across heterogeneous immune backgrounds. We investigated whether bronchoalveolar lavage fluid (BALF) immune profiling could identify disease-specific signatures for aspergillosis and Pneumocystis pneumonia. BALF samples from 27 patients were analyzed by shotgun proteomics using a Q Exactive Plus mass spectrometer coupled to an EASY-nLC1200 system. Clinical groups included invasive pulmonary aspergillosis (IPA, n = 7), chronic pulmonary aspergillosis (CPA, n = 4), Pneumocystis pneumonia (PCP, n = 4), Pneumocystis colonization (PCC, n = 4), bacterial infection (BI, n = 4), and controls (n = 4). Overall, 2,278 proteins were identified, with a median of 1,000 proteins per sample (IQR 902-1,384). Within-group pairwise Jaccard similarity was high for controls (median, 0.89), PCP (0.91), PCC (0.87) and BI (0.79), but lower for IPA (0.73) and CPA (0.62), indicating greater heterogeneity in aspergillosis. Hierarchical clustering largely grouped controls, BI, PCC, and PCP according to clinical diagnosis, whereas aspergillosis profiles were more variable. Two IPA clusters emerged: kidney transplant recipients, whose proteomic profiles resembled controls, and non-neutropenic patients with hematological malignancies. Analysis of 77 soluble immune mediators produced broadly similar clustering, suggesting that immune proteins may distinguish clinically relevant disease patterns. In this exploratory analysis, BALF immune proteomic profiles differed according to clinical diagnosis, with the most pronounced heterogeneity observed within aspergillosis. Complement proteins and antimicrobial peptides emerged as candidate biomarkers that warrant validation in larger, independent cohorts before their diagnostic utility can be established.
Zhou Xiaoxia X, Xu Kangli K, Zhang Lifang L, Qiu Wujie W et al.
Photoelectrocatalytic CO2 reduction reaction (PEC CO2RR) offers a promising avenue for the direct and clean conversion of solar energy into chemical fuels. In this work, Bi nanosheets with highly active (003) facets were successfully deposited on p-Si by precisely tuning the concentration of ethylenediaminetetraacetic acid disodium salt (EDTA-2Na) in the electrodeposition solution. In the PEC CO2RR reaction, the optimized photocathode exhibited high selectivity toward formate, with a Faradaic efficiency (FE) exceeding 80% over a wide potential range of -0.6 to -1.2 V vs. the reversible hydrogen electrode (RHE). The photoelectrode also demonstrated super stability, with both current density and product selectivity showing negligible decay during prolonged 10 h electrolysis. Critically, the introduction of the surfactant cetyltrimethylammonium bromide successfully suppressed the growth of the (003) facet in the electrodeposition process, resulting in a marked decrease in formate selectivity. This enhanced performance is attributed to the synergistic effects of the highly active (003) facet and the efficient photogenerated charge separation via the Schottky junction between Bi and p-Si. Besides, the introduction of a light field further increases the interfacial charge density and improves reaction kinetics at a lower overpotential. In situ infrared spectroscopy and density functional theory (DFT) calculations jointly confirm that the reaction proceeds via the critical *OCHO and *COOH intermediate pathway to efficiently produce formate, and the (003) facet possesses strong CO2 adsorption capability and a high driving force for hydrogenation, making it particularly favorable for the formation of the *COOH intermediate. This work proposes a precise facet engineering strategy, offering a new approach to address the key challenges of catalytic selectivity and charge separation efficiency in this system.
+9996 more articles available with a free account
Sign up free to view all articles →